{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:11:51Z","timestamp":1783123911009,"version":"3.54.6"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,3,22]],"date-time":"2016-03-22T00:00:00Z","timestamp":1458604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2016,3,22]],"date-time":"2016-03-22T00:00:00Z","timestamp":1458604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1038\/leu.2016.67","type":"journal-article","created":{"date-parts":[[2016,3,22]],"date-time":"2016-03-22T03:41:09Z","timestamp":1458618069000},"page":"1568-1579","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Development and analysis of patient-derived xenograft mouse models in intravascular large B-cell lymphoma"],"prefix":"10.1038","volume":"30","author":[{"given":"K","family":"Shimada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1838-4837","authenticated-orcid":false,"given":"M","family":"Nakatochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Suguro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Hirakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T D","family":"Hocking","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Tokunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Naoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Hayakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Seto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Kiyoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,22]]},"reference":[{"key":"BFleu201667_CR1","first-page":"252","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"S Nakamura","year":"2008","unstructured":"Nakamura S, Ponzoni M, Campo E . Intravascular large B-cell lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al (eds), WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press: Lyon, France, 2008; pp 252\u2013253."},{"key":"BFleu201667_CR2","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.1200\/JCO.2006.08.2313","volume":"25","author":"M Ponzoni","year":"2007","unstructured":"Ponzoni M, Ferreri AJ, Campo E, Facchetti F, Mazzucchelli L, Yoshino T et al. Definition, diagnosis, and management of intravascular large B-cell lymphoma: proposals and perspectives from an international consensus meeting. J Clin Oncol 2007; 25: 3168\u20133173.","journal-title":"J Clin Oncol"},{"key":"BFleu201667_CR3","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/annonc\/mdh274","volume":"15","author":"AJ Ferreri","year":"2004","unstructured":"Ferreri AJ, Campo E, Ambrosetti A, Ilariucci F, Seymour JF, Willemze R et al. Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma. Ann Oncol 2004; 15: 1215\u20131221.","journal-title":"Ann Oncol"},{"key":"BFleu201667_CR4","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1182\/blood-2006-01-021253","volume":"109","author":"T Murase","year":"2007","unstructured":"Murase T, Yamaguchi M, Suzuki R, Okamoto M, Sato Y, Tamaru J et al. Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5. Blood 2007; 109: 478\u2013485.","journal-title":"Blood"},{"key":"BFleu201667_CR5","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S0002-9343(02)01378-5","volume":"114","author":"S Gill","year":"2003","unstructured":"Gill S, Melosky B, Haley L, ChanYan C . Use of random skin biopsy to diagnose intravascular lymphoma presenting as fever of unknown origin. Am J Med 2003; 114: 56\u201358.","journal-title":"Am J Med"},{"key":"BFleu201667_CR6","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/S0025-6196(11)61097-5","volume":"82","author":"N Asada","year":"2007","unstructured":"Asada N, Odawara J, Kimura S, Aoki T, Kamakura M, Takeuchi M et al. Use of random skin biopsy for diagnosis of intravascular large B-cell lymphoma. Mayo Clin Proc 2007; 82: 1525\u20131527.","journal-title":"Mayo Clin Proc"},{"key":"BFleu201667_CR7","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00277-010-1101-3","volume":"90","author":"K Matsue","year":"2011","unstructured":"Matsue K, Asada N, Odawara J, Aoki T, Kimura S, Iwama K et al. Random skin biopsy and bone marrow biopsy for diagnosis of intravascular large B cell lymphoma. Ann Hematol 2011; 90: 417\u2013421.","journal-title":"Ann Hematol"},{"key":"BFleu201667_CR8","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1200\/JCO.2007.15.4278","volume":"26","author":"K Shimada","year":"2008","unstructured":"Shimada K, Matsue K, Yamamoto K, Murase T, Ichikawa N, Okamoto M et al. Retrospective analysis of intravascular large B-cell lymphoma treated with rituximab-containing chemotherapy as reported by the IVL study group in Japan. J Clin Oncol 2008; 26: 3189\u20133195.","journal-title":"J Clin Oncol"},{"key":"BFleu201667_CR9","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1365-2141.2008.07338.x","volume":"143","author":"AJ Ferreri","year":"2008","unstructured":"Ferreri AJ, Dognini GP, Bairey O, Szomor A, Montalban C, Horvath B et al. The addition of rituximab to anthracycline-based chemotherapy significantly improves outcome in 'Western' patients with intravascular large B-cell lymphoma. Br J Haematol 2008; 143: 253\u2013257.","journal-title":"Br J Haematol"},{"key":"BFleu201667_CR10","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S1470-2045(09)70140-8","volume":"10","author":"K Shimada","year":"2009","unstructured":"Shimada K, Kinoshita T, Naoe T, Nakamura S . Presentation and management of intravascular large B-cell lymphoma. Lancet Oncol 2009; 10: 895\u2013902.","journal-title":"Lancet Oncol"},{"key":"BFleu201667_CR11","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S0046-8177(00)80223-3","volume":"31","author":"M Ponzoni","year":"2000","unstructured":"Ponzoni M, Arrigoni G, Gould VE, Del Curto B, Maggioni M, Scapinello A et al. Lack of CD 29 (beta1 integrin) and CD 54 (ICAM-1) adhesion molecules in intravascular lymphomatosis. Hum Pathol 2000; 31: 220\u2013226.","journal-title":"Hum Pathol"},{"key":"BFleu201667_CR12","doi-asserted-by":"publisher","first-page":"222","DOI":"10.5414\/CNP65222","volume":"65","author":"T Kusaba","year":"2006","unstructured":"Kusaba T, Hatta T, Tanda S, Kameyama H, Tamagaki K, Okigaki M et al. Histological analysis on adhesive molecules of renal intravascular large B cell lymphoma treated with CHOP chemotherapy and rituximab. Clin Nephrol 2006; 65: 222\u2013226.","journal-title":"Clin Nephrol"},{"key":"BFleu201667_CR13","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nprot.2007.25","volume":"2","author":"CL Morton","year":"2007","unstructured":"Morton CL, Houghton PJ . Establishment of human tumor xenografts in immunodeficient mice. Nat Protoc 2007; 2: 247\u2013250.","journal-title":"Nat Protoc"},{"key":"BFleu201667_CR14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1532\/IJH97.07028","volume":"86","author":"A Tomita","year":"2007","unstructured":"Tomita A, Hiraga J, Kiyoi H, Ninomiya M, Sugimoto T, Ito M et al. Epigenetic regulation of CD20 protein expression in a novel B-cell lymphoma cell line, RRBL1, established from a patient treated repeatedly with rituximab-containing chemotherapy. Int J Hematol 2007; 86: 49\u201357.","journal-title":"Int J Hematol"},{"key":"BFleu201667_CR15","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/j.1349-7006.2005.00079.x","volume":"96","author":"MZ Dewan","year":"2005","unstructured":"Dewan MZ, Watanabe M, Ahmed S, Terashima K, Horiuchi S, Sata T et al. Hodgkin's lymphoma cells are efficiently engrafted and tumor marker CD30 is expressed with constitutive nuclear factor-kappaB activity in unconditioned NOD\/SCID\/gammac(null) mice. Cancer Sci 2005; 96: 466\u2013473.","journal-title":"Cancer Sci"},{"key":"BFleu201667_CR16","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1182\/blood-2001-12-0207","volume":"100","author":"M Ito","year":"2002","unstructured":"Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, Hioki K et al. NOD\/SCID\/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood 2002; 100: 3175\u20133182.","journal-title":"Blood"},{"key":"BFleu201667_CR17","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/sj.leu.2404432","volume":"21","author":"M Ninomiya","year":"2007","unstructured":"Ninomiya M, Abe A, Katsumi A, Xu J, Ito M, Arai F et al. Homing, proliferation and survival sites of human leukemia cells in vivo in immunodeficient mice. Leukemia 2007; 21: 136\u2013142.","journal-title":"Leukemia"},{"key":"BFleu201667_CR18","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","volume":"17","author":"JJ van Dongen","year":"2003","unstructured":"van Dongen JJ, Langerak AW, Bruggemann M, Evans PA, Hummel M, Lavender FL et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003; 17: 2257\u20132317.","journal-title":"Leukemia"},{"key":"BFleu201667_CR19","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1084\/jem.20040254","volume":"200","author":"T Katakai","year":"2004","unstructured":"Katakai T, Hara T, Sugai M, Gonda H, Shimizu A . Lymph node fibroblastic reticular cells construct the stromal reticulum via contact with lymphocytes. J Exp Med 2004; 200: 783\u2013795.","journal-title":"J Exp Med"},{"key":"BFleu201667_CR20","doi-asserted-by":"publisher","first-page":"5948","DOI":"10.1158\/0008-5472.CAN-03-4056","volume":"64","author":"H Tagawa","year":"2004","unstructured":"Tagawa H, Tsuzuki S, Suzuki R, Karnan S, Ota A, Kameoka Y et al. Genome-wide array-based comparative genomic hybridization of diffuse large B-cell lymphoma: comparison between CD5-positive and CD5-negative cases. Cancer Res 2004; 64: 5948\u20135955.","journal-title":"Cancer Res"},{"key":"BFleu201667_CR21","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1093\/bioinformatics\/btu072","volume":"30","author":"TD Hocking","year":"2014","unstructured":"Hocking TD, Boeva V, Rigaill G, Schleiermacher G, Janoueix-Lerosey I, Delattre O et al. SegAnnDB: interactive Web-based genomic segmentation. Bioinformatics 2014; 30: 1539\u20131546.","journal-title":"Bioinformatics"},{"key":"BFleu201667_CR22","doi-asserted-by":"publisher","first-page":"14863","DOI":"10.1073\/pnas.95.25.14863","volume":"95","author":"MB Eisen","year":"1998","unstructured":"Eisen MB, Spellman PT, Brown PO, Botstein D . Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998; 95: 14863\u201314868.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu201667_CR23","doi-asserted-by":"publisher","first-page":"5116","DOI":"10.1073\/pnas.091062498","volume":"98","author":"VG Tusher","year":"2001","unstructured":"Tusher VG, Tibshirani R, Chu G . Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001; 98: 5116\u20135121.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu201667_CR24","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102: 15545\u201315550.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu201667_CR25","first-page":"826","volume":"111","author":"T Murase","year":"2000","unstructured":"Murase T, Nakamura S, Kawauchi K, Matsuzaki H, Sakai C, Inaba T et al. An Asian variant of intravascular large B-cell lymphoma: clinical, pathological and cytogenetic approaches to diffuse large B-cell lymphoma associated with haemophagocytic syndrome. Br J Haematol 2000; 111: 826\u2013834.","journal-title":"Br J Haematol"},{"key":"BFleu201667_CR26","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","volume":"103","author":"CP Hans","year":"2004","unstructured":"Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004; 103: 275\u2013282.","journal-title":"Blood"},{"key":"BFleu201667_CR27","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/35000501","volume":"403","author":"AA Alizadeh","year":"2000","unstructured":"Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403: 503\u2013511.","journal-title":"Nature"},{"key":"BFleu201667_CR28","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/cas.12442","volume":"105","author":"M Suguro","year":"2014","unstructured":"Suguro M, Yoshida N, Umino A, Kato H, Tagawa H, Nakagawa M et al. Clonal heterogeneity of lymphoid malignancies correlates with poor prognosis. Cancer Sci 2014; 105: 897\u2013904.","journal-title":"Cancer Sci"},{"key":"BFleu201667_CR29","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1056\/NEJMoa012914","volume":"346","author":"A Rosenwald","year":"2002","unstructured":"Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 2002; 346: 1937\u20131947.","journal-title":"N Engl J Med"},{"key":"BFleu201667_CR30","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/nrm2786","volume":"10","author":"M Vicente-Manzanares","year":"2009","unstructured":"Vicente-Manzanares M, Ma X, Adelstein RS, Horwitz AR . Non-muscle myosin II takes centre stage in cell adhesion and migration. Nat Rev Mol Cell Biol 2009; 10: 778\u2013790.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFleu201667_CR31","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1126\/science.285.5429.895","volume":"285","author":"M Maekawa","year":"1999","unstructured":"Maekawa M, Ishizaki T, Boku S, Watanabe N, Fujita A, Iwamatsu A et al. Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. Science 1999; 285: 895\u2013898.","journal-title":"Science"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu201667.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201667","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201667.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:42:40Z","timestamp":1781916160000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu201667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,22]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["BFleu201667"],"URL":"https:\/\/doi.org\/10.1038\/leu.2016.67","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,22]]},"assertion":[{"value":"22 October 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K Sugimoto is an employee of Otsuka Pharmaceutical Co., Ltd and M Seto is an employee of Immuno-Biological Laboratories Co., Ltd. TN received research funding from Astellas Pharma Inc., Celgene KK, Fujifilm Corporation, Kyowa-Hakko Kirin Co., Ltd, Nippon Boehringer Ingelheim Co., Ltd, Otsuka Pharmaceutical Co., Ltd, Pfizer Inc. and Toyoma Chemical Co., Ltd, has issued patents and royalties with Chugai Pharmaceutical Co., Ltd, and Kyowa-Hakko Kirin Co., Ltd and has pending patents and royalties with Fujifilm Corporation. HK has served as a consultant for Astellas Pharma Inc. and Kyowa-Hakko Kirin Co., Ltd and has received research funding from Fujifilm Corporation, Nippon Boehringer Ingelheim Co., Ltd, Bristol-Myers Squibb, Chugai Pharmaceutical Co., Ltd, Kyowa-Hakko Kirin Co., Ltd, Zenyaku Kogyo Company Ltd, FUJIFILM RI Pharma Co., Ltd, Nippon Shinyaku Co., Ltd, the Japan Blood Products Organization, Astellas Pharma Inc., Eisai Co., Ltd, Yakult Honsha Co., Ltd, Pfizer Inc., Takeda Pharmaceutical Co., Ltd, MSD K.K., Alexion Pharmaceuticals, Teijin Ltd, Mochida Pharmaceutical Co., Ltd, Sumitomo Dainippon Pharma Co., Ltd, Taisho Toyama Pharmaceutical Co., Ltd and Novartis Pharma K.K. and has patents and royalties with Fujifilm Corporation.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}